Anaesthesia & intensive care medicine
Volume 10, Issue 4 , Pages 176-178 , April 2009

Haematological problems in intensive care

References 

  1. Dasta J, Mody SH, McLaughlin T, et al. Current management of anemia in critically ill patients: analysis of a database of 139 hospitals. Am J Ther. 2008;15:423–430
  2. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N Engl J Med. 1999;340:409–417
  3. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36:2667–2674
  4. Corwin HL, Gettinger A. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med. 2007;357:965–976
  5. Strauss R, Wehler M, Mehler K, et al. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med. 2002;30:1765–1771
  6. Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28:1871–1876
  7. Moreau D, Timsit JF, Vesin A, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest. 2007;131:1735–1741
  8. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care. 2006;10:222
  9. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral haemorrhage. N Engl J Med. 2005;352:777–785
  10. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med. 2001;344:699–709

PII: S1472-0299(09)00002-2

doi: 10.1016/j.mpaic.2009.01.001

Anaesthesia & intensive care medicine
Volume 10, Issue 4 , Pages 176-178 , April 2009

Article Tools